Abstract

The photoinduced CO‐releasing properties of [RuLPy(CO)2Cl2] (1), [Ru(LPy2Bz‐ĸ2N1,N2)(CO)2Cl2] (2), and [Ru(LPy2Bz–Et‐ĸ3N1,N2,N3)(CO)2(Cl)]·PF6 (3) [LPy = 2‐(2‐pyridyl)benzimidazole, LPy2Bz = 2,6‐bis(benzimidazole‐2′‐yl)pyridine, and LPy2Bz–Et = 2,6‐bis(1‐ethyl‐benzimidazol‐2′‐yl)pyridine] in both DMSO and reduced myoglobin solution are reported. Complexes 1 and 2 release CO upon illumination at 365 nm. The bidentate chelation mode of LPy2Bz in 2 is changed into a meridional tridentate mode upon the ethylation of the benzimidazolic NH groups, 3. The extension of the conjugation system and the shift of the MLCT band into the visible region in 3 give rise to the RuII dicarbonyl complex capable of releasing CO at 468 nm. During illumination of 2, the chelation mode of LPy2Bz is changed from ĸ2N1,N2 to ĸ3N1,N2,N3, as monitored by solution NMR spectroscopic studies. The spectral properties were studied by TD‐DFT calculations. The interaction of 1–3 with hen‐egg‐white lysozyme, as a biocompatible carrier, has been studied by ESI‐MS and UV/Vis spectroscopy in the dark and upon illumination. Stable protein adducts containing the RuII(CO)2 moiety, capable of photoinduced release of CO, are formed.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.